XML 105 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Statements of Cash Flows - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
OPERATING ACTIVITIES        
Net loss $ (1,712,193) $ (622,544) $ (1,341,333) $ (587,997)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and Amortization 777,338 7,330    
Stock-based compensation 129,657    
Changes in operating assets and liabilities:        
Inventory (90,033) (136,443) (65,318) (3,460)
Depreciation and Amortization     263,280 5,833
Accounts receivable 1,845 (1,845) 30,000
Prepaid expenses     (4,135)
Security deposit     (9,000)
Unearned Revenue 200,000    
Accounts payable and accrued liabilities 107,370 46,865 125,429 34,452
Net cash used in operating activities (586,016) (704,792) (1,019,787) (534,307)
INVESTING ACTIVITIES        
Purchases of property, plant and equipment (90,893) (90,893)
Net cash used in investing activities (90,893) (90,893)
FINANCING ACTIVITIES        
Due to related party     (30,507) (39,196)
Proceeds from related party promissory notes 618,679 803,079 1,138,570  
Proceeds from issuance common stock       216,192
Proceeds from members’ interest     140,500
Net cash provided by financing activities 618,679 803,079 1,108,063 317,496
Net change in cash 32,663 7,394 (2,617) (216,811)
Cash - Beginning of Period 6,191 8,808 8,808 225,619
Cash - End of Period 38,854 16,202 6,191 8,808
Supplemental Disclosure of Cash Flows Information:        
Cash paid for interest 104,643 9,128 41,837 495
Cash paid for income taxes    
Non-cash Investing and Financing Activities:        
Forgiveness of receivable – related party     146,617
ALTANINE, INC. [Member]        
OPERATING ACTIVITIES        
Net loss (4,581,010) (2,120,407) (3,236,717) (3,978)
Adjustments to reconcile net loss to net cash used in operating activities:        
Amortization deferred financing costs 203,397 161,122 241,684
Amortization intellectual property 445,221 296,814 445,221
Depreciation and Amortization 445,221 296,814 445,221
Change in fair value warrant liability 1,724,722 (64,537) (42,953)
Stock-based compensation 632,629 542,800 582,888
Changes in operating assets and liabilities:        
Prepaid expenses 9,814 5,474 (17,708)
Accounts payable 204,862 343,825 94,565
Accrued liabilities (1,682) (18,398) 366,854
Net cash used in operating activities (1,362,047) (853,307) (1,566,166) (3,978)
INVESTING ACTIVITIES        
Purchase of intellectual property (50,080) (50,080)
Net cash used in investing activities (50,080) (50,080)
FINANCING ACTIVITIES        
Proceeds from issuance common stock     4,500
Advances from related party 1,367,000 904,541 1,683,750
Repayment related party     (65,000)
Net cash provided by financing activities 1,367,000 904,541 1,618,750 4,500
Net change in cash 4,953 1,154 2,504 522
Cash - Beginning of Period 3,026 522 522
Cash - End of Period 7,979 1,676 3,026 522
Supplemental Disclosure of Cash Flows Information:        
Cash paid for interest
Cash paid for income taxes
Non-cash Investing and Financing Activities:        
Corporate expenses paid on behalf of the company 140,901    
Issuance of common stock for asset acquisition 9,903,880    
Acquisition intellectual property from asset acquisition     10,041,591
Issuance of common stock for asset acquisition     9,903,880
Accounts payable assumed from asset acquisition     137,711
Fair value warrants issued with line of credit 644,490 $ 644,490
Conversion of line of credit to preferred stock 1,000,000    
Cashless exercise of warrants 2,326,258    
Acquisition intellectual property from asset acquisition 10,041,591    
Accounts payable assumed from asset acquisition $ 137,711